Objective: People with diabetes (PWD) have limited access to healthcare professionals. To provide PWD with the support they need, there must be a comprehensive understanding of the daily burdens associated with self-management.
Methods: An on-line questionnaire using the dQ&A US Patient Panel was created to understand the daily burden associated with self-management. Respondents from this survey (n=3,241) included adults with type 1 diabetes (T1DM), adults with type 2 diabetes (T2DM) on intensive insulin therapy, adults with T2DM on non-intensive insulin therapy, and adults with T2DM not on insulin. The sample included demographic and health characteristics.
Results: 1,204 respondents had an annual income of less than $50,000. PWD in this income category are more likely to have housing and food insecurity and problems with paying their bills. Both PWD with an annual income of less than $50,000 and PWD with T1DM are more likely to report experiencing severe psychological and practical diabetes management burdens. PWD with T1DM are more likely to think about the impact of their diabetes on future events and experience sleep disruptions on a weekly basis.
Conclusion: Concerns about long-term health and food choices are the leading causes of distress for all groups. Respondents have more difficulty ‘affording’ rather than ‘accessing’ items/facilities. There are many burdens related to diabetes, many caused by SDOH.
K. Yehl: None. S.A. Fields: None. F. Lee: Employee; Sanofi. Stock/Shareholder; Sanofi. E. Shoger: Other Relationship; Dexcom, Inc., Abbott, Tandem Diabetes Care, Inc., Beta Bionics, Inc., MannKind Corporation, Insulet Corporation, Medtronic, Association of Diabetes Care & Education Specialists. R. Smallman: None. K.A. Ellbogen: None. D. Kerr: Advisory Panel; Abbott Diagnostics. Consultant; Sanofi, Better Therapeutics, Inc. Stock/Shareholder; Glooko, Inc.
Sanofi US (77230685)
